SCHEMBL14701086

SCHEMBL14701086

Cl/N=N/c1ccc(Cl)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
TP53 P04637 2/20 0.46
ITGB3 P05106 1/20 0.46
ITGAV P06756 1/20 0.46
IDO1 P14902 1/20 0.41
TSHR P16473 6/20 0.41
CYP3A4 P08684 4/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 3/20 0.38
MAPK1 P28482 2/20 0.38
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37
GFER P55789 1/20 0.37
PTPN11 Q06124 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15188822 0.81 CYP3A4 (0.46) MEN1KMT2AMAPTTP53ITGB3
SCHEMBL28551704 0.74 CASP3 (0.62) MEN1KMT2ALMNAGAAMAPT
SCHEMBL28551702 0.74 CASP3 (0.62) MEN1KMT2ALMNAGAAMAPT
SCHEMBL9290659 0.73 TP53 (0.48) MEN1KMT2ALMNAGAAMAPT
SCHEMBL31218219 0.73 TP53 (0.48) MEN1KMT2ALMNAGAAMAPT
SCHEMBL1547648 0.73 TP53 (0.48) MEN1KMT2ALMNAGAAMAPT
SCHEMBL12440436 0.73 TP53 (0.48) MEN1KMT2ALMNAGAAMAPT
SCHEMBL11849969 0.73 ITGB3 (0.56) MEN1KMT2ALMNAGAAMAPT
SCHEMBL14701084 0.72 MAPK1 (0.36) TSHRCYP3A4HSD17B10MAPK1AHR
SCHEMBL11492006 0.71 TP53 (0.46) MEN1KMT2ALMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121285-A1 Selective androgen receptor modulators RADIUS HEALTH INC (US) 2017-05-04 US disclosed
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2015-09-24 US disclosed
US-8987319-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2015-03-24 US disclosed
US-20130041007-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121285-A1 Selective androgen receptor modulators AR, SHBG, FSHR MEN1 2349/4885KMT2A 3022/4885LMNA 1424/4885
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS AR, SHBG, FSHR MEN1 2363/4885KMT2A 2996/4885LMNA 1414/4885
US-20130041007-A1 Selective Androgen Receptor Modulators AR, SHBG, GPR119 MEN1 2213/4885KMT2A 3850/4885LMNA 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.